Community Listing, Free
Challenges in Trial Design for Psychedelic-Assisted Therapies: University of Michigan Medical School Michigan Psychedelic Center
Fueled by positive findings from clinical trials, psychedelic research has returned to mainstream psychiatry and neuroscience, with a growing number of studies examining a wide range of conditions. However, expectancy effects and effective condition blinding have been raised as critical limitations to the interpretability of this research.
In this talk, Jacob Aday, PhD, will review the many methodological challenges of conducting psychedelic clinical trials and provide recommendations for improving the rigor of future research.
This talk is part of the Michigan Psychedelic Center's 2026 Seminar Series: Psychedelics — From Cells to Society.
https://umich.zoom.us/j/97773094165, Online. Free. https://michmed.org/rwYjRAdd this event to your calendar: Google | iCal